PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche. The strategic partnership will allow PathAI to develop and distribute its AI ...

This is How I Got Here, a series where we chart the career journeys of technologists, entrepreneurs, tech workers, builders and people in the innovation economy. Want to tell your story? Get in touch.

Globally the digital transformation of pathology is gaining momentum. This is being seen across health and pharmaceutical sectors; together with education establishments and contract research ...

While medical science is a specialist area it is not immune from the pressures faced by other workplaces. This takes the form of an increasing number of tests, and corresponding demand for faster, ...

According to the research – which explores the next decade or so for digital whole slide scanning, imaging solutions, data repository and more – changes are coming for those technologies (and those ...

Massachusetts General Hospital and Philips are embarking on a clinical analytical study to gauge the effectiveness of digital alternatives for pathology work. The project will assess Philips’ ...

AI-enabled pathology company PathAI has entered into a multiyear drug discovery partnership with pharma giant GlaxoSmithKline. The agreement will focus on advancing clinical trials and drug ...

Digital pathology company 3Scan has raised a $14 million Series B to flesh out its image processing and analysis software and to increase its presence in the drug discovery field. Lux Capital and Data ...